Hot Watch List: Applied Genetic Technologies (NASDAQ:AGTC), Vital Therapies (NASDAQ:VTL), Phibro Animal Health (NASDAQ:PAHC), Kindred Healthcare (NYSE:KND), Amsurg (NASDAQ:AMSG)

Applied Genetic Technologies Corp (NASDAQ:AGTC) had its price target increased by BMO Capital Markets from $21.00 to $34.00. The firm currently has an outperform rating on the stock. Applied Genetic Technologies Corp (NASDAQ:AGTC) weekly performance is 26.26%. On last trading day company shares ended up $25.29. Analysts mean target price for the company is $22.75. Applied Genetic Technologies Corp (NASDAQ:AGTC) distance from 50-day simple moving average is 76.45%.

Vital Therapies (NYSE:VTL) issued its quarterly earnings data on Tuesday. The company reported ($24.49) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.54) by $23.95. Vital Therapies Inc (NASDAQ:VTL) shares in last trading session and ended the day on $19.60.

The Norwegian vaccine company Vaccibody and Phibro Animal Health Corp (NASDAQ:PAHC), a global animal health and mineral nutrition company, have signed a global exclusive license agreement which grants Phibro and its affiliates the right to develop, market and sell novel vaccines for the poultry market using the Vaccibody platform technology. Phibro Animal Health Corp (NASDAQ:PAHC) shares moved up 1.10% in last trading session and was closed at $21.99, while trading in range of $21.61-$22.62. Phibro Animal Health Corp (NASDAQ:PAHC) year to date performance is 29.35%.

Louisville, Ky.-based Kindred Healthcare, Inc. (NYSE:KND) is closing two Texas hospitals and eliminating 246 jobs, according to a Houston Chronicle report. Kindred Healthcare, Inc. (NYSE:KND) ended the last trading day at $26.59. Company weekly volatility is calculated as 2.67% and price to cash ratio as 10.05. Kindred Healthcare, Inc. (NYSE:KND) showed a positive weekly performance of 6.27%.

Amsurg Corp (NASDAQ:AMSG) was upgraded by analysts at Deutsche Bank from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday. Amsurg Corp (NASDAQ:AMSG) net profit margin is 6.70% and weekly performance is 10.21%. On last trading day company shares ended up $52.36. Analysts mean target price for the company is $49.86. Amsurg Corp (NASDAQ:AMSG) distance from 50-day simple moving average is 16.47%.